Rebetol and Buttock pain - a phase IV clinical study of FDA data

Summary:

Buttock pain is reported only by a few people who take Rebetol.

The phase IV clinical study analyzes which people take Rebetol and have Buttock pain. It is created by eHealthMe based on reports of 25,882 people who have side effects while taking Rebetol from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 22, 2022

25,882 people reported to have side effects when taking Rebetol.
Among them, 3 people (0.01%) have Buttock pain.


What is Rebetol?

Rebetol has active ingredients of ribavirin. eHealthMe is studying from 25,907 Rebetol users for its effectiveness, alternative drugs and more.

What is Buttock pain?

Buttock pain is found to be associated with 378 drugs and 184 conditions by eHealthMe.

Number of Rebetol and Buttock pain reports submitted per year:

Could Rebetol cause Buttock pain?

Time on Rebetol when people have Buttock pain *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Buttock pain when taking Rebetol *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who have Buttock pain when taking Rebetol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 66.67 %

Common drugs people take besides Rebetol *:

  1. Peg-Intron: 2 people, 66.67%
  2. Tagamet: 1 person, 33.33%
  3. Norvasc: 1 person, 33.33%

Common side effects people have besides Buttock pain *:

  1. Herpes Zoster: 2 people, 66.67%
  2. Scab (a hard coating on the skin formed during the wound healing): 1 person, 33.33%
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 33.33%
  4. Injection Site Ulcer: 1 person, 33.33%
  5. Injection Site Pain: 1 person, 33.33%
  6. Injection Site Necrosis (death of body tissue at injection site): 1 person, 33.33%
  7. Injection Site Induration: 1 person, 33.33%
  8. Immune System Disorder: 1 person, 33.33%
  9. Accident: 1 person, 33.33%

Common conditions people have *:

  1. Hepatitis C: 3 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rebetol and have Buttock pain?

Check whether Buttock pain is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Buttock pain and when was it recovered:

Expand to all the drugs that have ingredients of ribavirin:

Alternative drugs to, pros and cons of Rebetol:

Common Rebetol side effects:

Browse all side effects of Rebetol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Buttock pain treatments and more:

COVID vaccines that are related to Buttock pain:

All the drugs that are associated with Buttock pain:

All the conditions that are associated with Buttock pain:

How the study uses the data?

The study uses data from the FDA. It is based on ribavirin (the active ingredients of Rebetol) and Rebetol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: